Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: SERV stock price vs MDT: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at MDT's multiple
Needs MDT P/S.
Implied fair value · at SERV's multiple
Needs SERV P/S.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
13 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
SERVE ROBOTICS INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Medtronic plc · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
TERADYNE, INC
SERV vs TER
IROBOT CORP
SERV vs IRBT
DEXCOM INC
SERV vs DXCM
COGNEX CORP
SERV vs CGNX
ROCKWELL AUTOMATION, INC
SERV vs ROK
UiPath, Inc.
SERV vs PATH
Abbott Laboratories
SERV vs ABT
Johnson & Johnson
SERV vs JNJ
STRYKER CORP
SERV vs SYK
BECTON DICKINSON & CO
SERV vs BDX
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe SERV can rapidly scale revenue while sharply improving margins toward profitable MDT-like levels, then the stock could merit patience; otherwise, the data support reducing exposure because SERV trades at extreme valuation multiples without corresponding profitability or quality.
SERV trades at a massive premium to MDT despite far weaker financials, with the comparison implying a downside of 98.1% to MDT-based price. The gap is driven by SERV’s extremely high sales multiple and negative earnings power rather than any fundamental resemblance to MDT.
Supporting Metrics
